The largest database of trusted experimental protocols

22 protocols using cxcl5

1

Plasma Cytokine Profiling in Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma prepared from blood of patients was tested for CXCL5, IL-8, IL-6, IL-17A using specific enzyme-immunoassays according to manufacturer’s instructions (CXCL5 from R&D Systems, Oxford, U.K.; IL-6; IL-8 and IL-17A from Peprotech, NJ, U.S.A.)
+ Open protocol
+ Expand
2

Boyden Chamber Assay for Cell Migration

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Neuro Probe AP48 48‐well Boyden chamber (Neuro Probe) was used for all assays. The chamber was prepared by adding 26 μL pre‐warmed (37℃) CXCL‐5 (0, 0.5, 50, 500 ng/mL) or CCL2 (0, 0.5, 50, 500 ng/mL) (R&D systems) in DMEM to the lower chamber. A filter membrane of either 3 μM (neutrophils) or 5 μM (Macrophages) pore size (Neuroprobe) was then placed on top of the lower chamber. The silicone gasket and the upper plate were then placed on top of the membrane and the membranes were sealed together with a thumb nuts. 50 000 cells of interest in 50 μL of DMEM were added to the top chamber avoiding air bubbles. The Boyden chamber was then placed in an incubator at 37℃ and 5% CO2 for 30 minute or 2 hours. The media was then removed from the top and bottom chambers and the number of cells was counted to obtain a percentage of cells which migrated into the bottom chamber.
+ Open protocol
+ Expand
3

Chemokine Cross-Reactivity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cross-reactivity was observed in the presence of 10 ng/mL of C–C motif chemokine ligand, including (CCL)1, CCL2, CCL3, CCL4, CCL5, CCL7, CCL8, CCL11, CCL12, CCL13, CCL14, CCL15, CCL16, CCL17, CCL18, CCL19, CCL22, CCL23, CCL24, CCL25, CCL26, CCL27, CCL28, CXCL1, CXCL2, CXCL3, CXCL4, CXCL5, CXCL6, CXCL7, CXCL8, CXCL10, CXCL11, CXCL12, CXCL13, CXCL14, CXCL16, and CXCL17 (R&D Systems).
+ Open protocol
+ Expand
4

Cytokine and Chemokine Quantification in Colon Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Resected colon tissue was sonicated for 40 seconds in RIPA lysis buffer supplemented with a protease inhibitor and 1 mM PMSF, and the tubes were gently inverted. The tissue samples were incubated on ice and centrifuged at 14,000 × g and 4°C. The supernatant was transferred to a fresh tube, and the total protein concentration was quantified using a BCA assay (Thermo Fisher Scientific). The concentrations of IL-1β, TNF-α, IL-6 (Thermo Fisher Scientific), CXCL1, CXCL2, and CXCL5 (R&D Systems Minneapolis, MN) were measured using ELISA kits. All procedures were performed according to the manufacturers' instructions. The levels of targeted molecules in tissues were expressed relative to the total protein concentration.
+ Open protocol
+ Expand
5

Neutrophil Migration Towards Chemoattractants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neutrophil migration toward CXCL5, CXCL8, LTB4, and C5a was measured in a 48-well micro chemotaxis chamber (Neuro Probe, Gaithersburg, MD, USA) as described (12 (link)). LTB4 and CXCL8 (72 AA) were bought from Peprotech (Rocky Hill, NY, USA), complement component C5a from Sigma (St. Louis, MO, USA) and CXCL5 from R&D Systems (Abingdon, UK). In every assay, a reference adult control (healthy member of the laboratory staff) was included in order to allow normalization. Migration of the PCD PMN was expressed relative to migration of the reference adult control. The same approach (i.e., standardization to the healthy adult control) was used to study the migration of PMN from healthy children. Before we tested the migration of neutrophils from patients with PCD, we first tested dose–response curves of healthy neutrophils to determine the optimal concentration of chemoattractant to be tested with patient cells.
+ Open protocol
+ Expand
6

Cytokine and Bone Marker Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood was collected via cardiac puncture at euthanasia, serum was isolated, and stored at −80°C. IL17A (Quantikine, R&D Systems), TNF (Quantikine, R&D Systems), P1NP (Immunodiagnostics Systems Inc, Gaithersburg, MD, USA), and TRAP5b (Immunodiagnostics Systems Inc) were assessed in serum isolates. CXCL1 (Quantikine, R&D Systems), CCL2 (Quantikine, R&D Systems), and CXCL5 (Quantikine, R&D Systems) was evaluated in osteoblast culture supernatants. ELISA kits were used following manufacturer’s protocols. All reactions were performed in triplicate.
+ Open protocol
+ Expand
7

Pancreatic Islet Isolation and Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pancreatic islets were isolated by collagenase-P digestion (Roche Diagnostics, Indianapolis, IN) followed by centrifugation with Histopaque 1100 (Sigma-Aldrich, St. Louis, MO) as previously described (Carter, et al. 2009 (link)). Islets were incubated overnight in RPMI 1640 medium (Invitrogen) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin to allow recovery from collagenase digestion before further treatment. Various islet stressors were prepared as follows: Rotenone and thapsigargin were purchased from Sigma-Aldrich and prepared in stocks of DMSO to final concentrations less than 0.1%. Glucose-free RPMI medium (10% FBS and 1% penicillin/streptomycin) was supplemented with 1M glucose stock to produce the 28G condition. Stocks of the murine forms of IL-1B, IL-6, CXCL1, and CXCL5 (purchased from R&D Systems, Inc., Minneapolis, MN) were prepared in PBS with 0.1% BSA. Oleate, linOleate, and palmitate were purchased from Sigma-Aldrich and were prepared in 100mM stock concentrations in methanol and stored in -80. To treat the islets, the required amount of each fatty acid was taken in a glass tube and dried under a stream of nitrogen to remove methanol. The dried mixture of fatty acids thus obtained was resuspended in the RPMI medium with 0.1% BSA followed by vortexing and sonication. All experiments were completed within 48-72 hours post isolation.
+ Open protocol
+ Expand
8

Quantifying Inflammatory Markers in Cell Supernatants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse IL-17A, human S100A8/A9 heterodimer, CXCL1, CXCL5 and interleukin (IL)-8 (R and D Systems, Minneapolis, MN, USA) and β-defensin 2 (Peprotech, Rocky Hill, NJ, USA) in cell culture supernatants were measured by using commercially available enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer’s instructions.
+ Open protocol
+ Expand
9

Leukocyte Adhesion Assay on ICAM1

Check if the same lab product or an alternative is used in the 5 most similar protocols
BM leukocytes (105 cells) were prepared in serum-/phenol red-free RPMI medium and stimulated with Cxcl5 (100 ng/ml, 1 h, R&D systems) prior to plating in black opaque 96-well plates coated with BSA (2 % w/v) or ICAM1 (1 μg/well) for 40 min (37 °C). Plates were prepared by coating wells with protein overnight and treated with BSA (1 % w/v, 1 h) to inhibit non-specific interactions prior to addition of leukocytes. Non-adherent leukocytes were removed by washing with Ca2+/Mg2+-free PBS. Adherent leukocytes were labeled with calcein AM (5 μM, 1 h), quantified by spectrophotometry (absorbance 485 nm), and expressed as a percentage of absorbance of 105 labeled cells.
+ Open protocol
+ Expand
10

Cytokine and Chemokine Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytokines and chemokines were determined by ELISA (IL-1β and IL-10, Biolegend, San Diego, USA; CXCL5, R&D Systems, Minneapolis, USA; CXCL1 and CCL5, PeproTech, Rehovot, Israel; IL-6, TNF-α, IFN-γ, and IL-17A, ebioscience, San Diego, USA). NE activity was measured by Neutrophil Elastase Activity Assay Kit (Cayman, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!